Modulation of Wnt signalling by inhibiting Notum offers an opportunity to target situations when Wnt signalling upregulation may be beneficial, such as Alzheimer's disease and osteoporosis. The gene discussed is NOTUM; the disease is early-onset autosomal dominant Alzheimer disease.